Compare the Safety and Effectiveness of Genoss® DCB and SeQuent® Please NEO in Chinese Patients with Coronary ISR

NACompletedINTERVENTIONAL
Enrollment

224

Participants

Timeline

Start Date

January 30, 2021

Primary Completion Date

December 20, 2023

Study Completion Date

May 30, 2024

Conditions
Coronary Artery Disease
Interventions
DEVICE

Paclitaxel Coated PTCA Balloon Catheter(Genoss® DCB)

Drug Coated Balloon

DEVICE

Paclitaxel Coated PTCA Balloon Catheter(SeQuent® Please NEO)

Drug Coated Balloon

Trial Locations (1)

710032

Department of Cardiology, First Affiliated Hospital of Air Force Medical University of Chinese PLA, Xi'an

All Listed Sponsors
lead

Genoss Co., Ltd.

INDUSTRY

NCT04767022 - Compare the Safety and Effectiveness of Genoss® DCB and SeQuent® Please NEO in Chinese Patients with Coronary ISR | Biotech Hunter | Biotech Hunter